Journal of Dermatological Treatment

Papers
(The H4-Index of Journal of Dermatological Treatment is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis105
Topical delgocitinib for the treatment of chronic hand eczema65
Skin type classifications: does the perfect assessment exist?64
A systematic review of recent randomized controlled trials for palmoplantar pustulosis47
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist44
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most43
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy43
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab38
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso35
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks34
Lessons from a decentralized trial in atopic dermatitis: promises and perils33
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial31
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa29
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)25
Finally, successful interventions to ameliorate cutaneous infestations25
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants25
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients23
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)22
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry22
A pediatric case of dupilumab-induced pustular psoriasis22
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study21
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study21
The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy21
0.24984002113342